... in patients undergoing radical nephroureterectomy followed platinum-based adjuvant chemotherapy. Methods: Pathological samples of 146 UTUC with clinical stage T2 and above undergoing radical nephrectomy (RNU) were collected. All patients received adjuvant cisplatin-based chemotherapy and 40 UTUC patients...

...Jinhyung Jeon; Jae Heon Kim; Jee Soo Ha; Won Jae Yang; Kang Su Cho; Do Kyung Kim Introduction: The objective of this study was to determine effects of adjuvant chemotherapy (AC) on survival outcomes compared to surgery alone without AC for upper tract urothelial carcinoma (UTUC) patients...

... (a), common number of administered cycles of NAC and AC (b), and chemotherapy regimen usually used in cisplatin ineligible patients (c). AC, adjuvant chemotherapy; NAC, neoadjuvant chemotherapy. Fig. 1. Utilization of NAC and AC (a), common number of administered cycles of NAC and AC (b), and chemotherapy...

...Y. Uekado; A. Hirano; T. Shinka; T. Ohkawa Thirty-seven patients who had undergone radical cystectomy and pelvic node dissection for pathologic stage pT2–4 and/or N+ disease received adjuvant chemotherapy involving the injection of cis -platinum alone or in its combination from June 1982 to April...

... Chemotherapy Adjuvant chemotherapy Abstract. A prospective multicenter phase-two study was initiated in 1983 to evaluate the effect of systemic chemotherapy after complete resection of TI G3-4 and T2 bladder carcinomas. Chemotherapy consisted of three cycles of cisplatin alone, a modified MVAC scheme...